Probiotics in inflammatory bowel disease: yet another mechanism of action?
Fiocchi
Claudio
C
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology; D002465:Cell Movement / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control*; D007371:Interferon-gamma / Q000378:metabolism; D008198:Lymph Nodes / Q000473:pathology; D008643:Mesentery / Q000473:pathology; D051379:Mice; D016513:Mice, SCID; D016328:NF-kappa B / Q000378:metabolism; D019936:Probiotics / Q000494:pharmacology* / Q000627:therapeutic use*; D012440:Saccharomyces / Q000502:physiology*
D016328:NF-kappa B; D007371:Interferon-gamma